The following list provides an overview of clinical registries that were formerly run by the Institute of Biostatistics and Analyses Ltd. An overview of current clinical registries is also available.
Terminated clinical registry of patients with acute heart failure.
Terminated clinical registry of patients with chronic myeloid leukaemia (CML) for the Arab Leukaemia Network.
Terminated clinical registry of patients suffering from age-related macular degeneration (AMD) or diabetic macular oedema (DMO) who were treated with anti-VEGF medications.
Terminated survey of patient compliance and the administration of antiplatelet therapy in patients with acute coronary syndrome who have been hospitalised in PCI centres all over the Czech Republic.
Terminated clinical registry of breast cancer patients who were treated with trastuzumab (Herceptin®), lapatinib (Tyverb®), bevacizumab (Avastin®) and/or everolimus (Afinitor®).
International clinical registry of patients with chronic myeloid leukaemia.
Terminated clinical registry of patients suffering from severe persisting allergic asthma who were treated with omalizumab (Xolair®).
Terminated clinical registry of colorectal cancer (CRC) patients who were treated with cetuximab (Erbitux®), bevacizumab (Avastin®) and/or panitumumab (Vectibix®).
Terminated clinical registry of patients with acute coronary syndromes in the Czech Republic.
Terminated cross-sectional registry of patients with acute coronary syndromes in the Czech Republic.
Terminated clinical registry of patients with food allergies.
Terminated multicentre, national, observational, non-interventional, prospective study of paediatric patients with an acute infection of respiratory tract who were treated with erdosteine (Erdomed®).
Terminated international project covering the Central European region and focusing on the collection and analysis of data on haemophiliac patients, including health care quality assessment.
Terminated registry of patients with hereditary gynaecological cancers, including breast cancer.
Terminated registry of morphologically examined breast cancers, with particular emphasis on the collection of data regarding the examination of HER2/neu status in the Czech population.
Multicentric non-interventional prospective study assessing antiemetic guidelines consistency in chemotherapy-induced nausea and vomiting (CINV) prophylaxis and the impact of CINV on the quality of life on cancer patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC).
Terminated international clinical registry gathering data on the management of patients with non-small cell lung cancer (NSCLC) who had been diagnosed at the clinical stage III.
Terminated clinical registry focused on the practice of anaesthesiology in obstetrics.
Terminated clinical registry of ovarian cancer patients who were treated with bevacizumab (Avastin®) and/or olaparib (Lynparza®).
Terminated parametric collection of basic clinical data on paediatric cancer patients, interactive analytical reports.
Clinical registry of pleural mesothelioma patients who have been treated with pemetrexed (Alimta®).
Terminated project developing a data background for the monitoring of numbers and indications of PET/CT scans in the clinical practice of Czech health care facilities.
Terminated clinical registry of patients with chronic obstructive pulmonary disease (COPD) in Central and Eastern Europe.
Terminated registry of PAH (pulmonary arterial hypertension) patients who were treated with parenteral prostanoids.
Terminated registry of paediatric and adult patients with home-administered parenteral nutrition.
Terminated clinical registry that monitored the epidemiology of gastrointestinal stromal tumours (GIST) as well as therapeutic approaches and treatment results in GIST patients in the Czech Republic and Slovakia.
The portal rektum.cz is dedicated mainly to the education of health care professionals on the issue of rectal cancer, which is diagnosed as C20 under the ICD-10 classification.
Terminated clinical registry of kidney cancer patients who were treated with bevacizumab (Avastin®), everolimus (Afinitor®), pazopanib (Votrient®), sorafenib (Nexavar®), sunitinib (Sutent®) and/or temsirolimus (Torisel®).
Terminated clinical registry of patients suffering from sellar tumours.
Terminated clinical registry of patients who underwent autologous stem cell transplantation and who were treated with plerixafor.
Registry of patients with essential thrombocythaemia or thrombocythaemia associated with another myeloproliferative disorder who have been treated with anagrelide (Thromboreductin®).